Skip to main content
Signal8

EBSWORTH DAVID R

SEC insider (Form 3/4/5 filer). CIK 0001207107. Director at Verona Pharma plc (VRNA). 15 reported Form 4/5 transactions since Sep 2024; latest on Oct 7, 2025. Located in LONDON, X0.

Companies EBSWORTH DAVID R has filed insider reports for

  • Verona Pharma plc (VRNA): Director
EBSWORTH DAVID R profile photo

EBSWORTH DAVID R

CIK: 0001207107

Transaction Breakdown

Open Market Buys (P)2 (13.3%)

High conviction signal

Open Market Sales (S)1 (6.7%)

Position reduction

Option Exercises (M)7 (46.7%)

Derivative conversions

Awards (A)1 (6.7%)

Compensation grants

Other (G, F, J, C, D, …)4 (26.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Verona Pharma plc logo
VRNA

Verona Pharma plc

Director

Discretionary Trading P&L

Holdings

Transaction History (15 total)

  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Disposition
    Direct
    880.5K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Exercise
    Direct
    72K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Disposition
    Direct
    72K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Oct 7, 2025
    Disposition
    Indirect
    617.6K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Aug 1, 2025
    Exercise
    Direct
    24K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Aug 1, 2025
    Sale
    Direct
    1.9K shares at avg. $13.14$25K
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    May 1, 2025
    Exercise
    Direct
    140K shares at avg. $1.93$271K
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Apr 25, 2025
    Award

    Restricted Share Units

    Direct
    96K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Feb 26, 2025
    Gift
    Direct
    64K shares-
  • Verona Pharma plc logo
    VRNA

    Verona Pharma plc

    Feb 26, 2025
    Exercise
    Direct
    96K shares at avg. $2.67$256K

1-10 of 15